Skip to main
GRDN

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Service is a leading provider of long-term care facility pharmacy services, with a strong focus on technology-enabled services. The company has a clean balance sheet and is well-positioned for growth in the fragmented long-term care pharmacy industry. Its improved vaccine business and strong financial flexibility make it a potential target for consolidation in the industry, while its strong performance and steady growth support a positive outlook on the company's stock.

Bears say

Guardian Pharmacy Service is facing increasing competition in the pharmacy services industry, with the rise of specialty pharmacies and larger players entering the market. This has resulted in slower revenue growth and potentially lower margins for the company. Additionally, the company's reliance on the LTCF segment for revenue leaves it exposed to potential changes in reimbursement policies, and any negative impacts could lead to further financial strain for the company.

GRDN has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Strong Buy based on their latest research and market trends.

According to 5 analysts, GRDN has a Strong Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $41.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $41.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.